← FDA DRUG APPROVALS

FDA ANDA · ANDA205740

ENTECAVIR

Sponsor: HETERO LABS LTD V

APPLICATION
ANDA205740
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-21
LATEST ACTION
2019-05-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ENTECAVIRPrescription
ENTECAVIR 1MG · TABLET · ORAL
ENTECAVIRPrescription
ENTECAVIR 0.5MG · TABLET · ORAL

Approval history

2019-05-31Labeling · Supplement 2 · standardAP
2019-05-31Labeling · Supplement 3 · standardAP
2015-08-21UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →